Key facts
- This page summarizes Ryan L. Vardeman's Form 4 filing for INTEVAC INC.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Nov 2024, 10:14.
Ryan L. Vardeman - 12 Nov 2024 Form 4 Insider Report for INTEVAC INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 12 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Nov 2024, 10:14:00 UTC
- Prior SEC filing
- 13 Nov 2024
- Next SEC filing
- 01 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan L. Vardeman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ryan L. Vardeman filed Form 4 for INTEVAC INC on 14 Nov 2024.
Change
- Previous filing in this sequence was filed on 13 Nov 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IVAC
transaction
Intevac Common Stock
Award
- Transaction value
- $0
- Shares
- +12,000
- Change %
- Price
- $0.000000
- Shares after
- 12,000
- Date
- 12 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
IVAC
holding
Intevac Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,053,924
- Date
- 12 Nov 2024
- Ownership
- See Footnotes
- Footnotes
- F2, F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IVAC
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +10,300
- Change %
- Price
- $0.000000
- Shares after
- 10,300
- Date
- 12 Nov 2024
- Ownership
- Direct
- Underlying class
- Intevac Common Stock
- Underlying amount
- 10,300
- Exercise price
- $2.55
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
These are restricted stock units awarded to the Reporting Person and each restricted stock unit represents a contingent right to receive one share of IVAC common stock. The restricted stock units will vest on 5/15/2025.
Footnote F2
This statement is filed by and on behalf of Ryan L. Vardeman. Palogic Value Fund, L.P., a Delaware limited partnership (Palogic Value Fund), is the record and direct beneficial owner of the securities covered by this statement. Palogic Value Management, L.P., a Delaware limited partnership (Palogic Value Management), is the general partner of, and may be deemed to beneficially own securities owned by, Palogic Value Fund. Palogic Capital Management, LLC, a Delaware limited liability company (Palogic Capital Management), is the general partner of, and may be deemed to beneficially own securities beneficially owned by, Palogic Value Management. Mr. Vardeman is the sole member of, and may be deemed to beneficially own securities beneficially owned by, Palogic Capital Management. Mr. Vardeman is also a limited partner in, and may be deemed to beneficially own securities owned by, Palogic Value Fund.
Footnote F3
The reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended or otherwise, the beneficial owner of any securities covered by this statement. The reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the reporting person in such securities. The reporting person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934.
Footnote F4
The reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such persons are, for the purposes of Section 13(d) or 13(g) of the Securities Exchange Act of 1934 or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
Footnote F5
This option shall be exercisable, in whole or in part on May 15, 2025.